Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies.
Venema CM, Mammatas LH, Schröder CP, van Kruchten M, Apollonio G, Glaudemans AWJM, Bongaerts AHH, Hoekstra OS, Verheul HMW, Boven E, van der Vegt B, de Vries EFJ, de Vries EGE, Boellaard R, Menke van der Houven van Oordt CW, Hospers GAP. Venema CM, et al. Among authors: mammatas lh. J Nucl Med. 2017 Dec;58(12):1906-1912. doi: 10.2967/jnumed.117.193649. Epub 2017 Sep 14. J Nucl Med. 2017. PMID: 28912144 Free article. Clinical Trial.
FDG PET and FES PET Predict PFS on Endocrine Therapy-Letter.
Mammatas LH, van Helden EJ, Verheul HMW, Menke-van der Houven van Oordt CW. Mammatas LH, et al. Clin Cancer Res. 2018 Jan 1;24(1):248. doi: 10.1158/1078-0432.CCR-17-2380. Clin Cancer Res. 2018. PMID: 29298807 No abstract available.
Visual and quantitative evaluation of [18F]FES and [18F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study.
Mammatas LH, Venema CM, Schröder CP, de Vet HCW, van Kruchten M, Glaudemans AWJM, Yaqub MM, Verheul HMW, Boven E, van der Vegt B, de Vries EFJ, de Vries EGE, Hoekstra OS, Hospers GAP, der Houven van Oordt CWM. Mammatas LH, et al. EJNMMI Res. 2020 Apr 19;10(1):40. doi: 10.1186/s13550-020-00627-z. EJNMMI Res. 2020. PMID: 32307594 Free PMC article.
11C-Sorafenib and 15O-H2O PET for Early Evaluation of Sorafenib Therapy.
Mammatas LH, Yaqub M, Hendrikse NH, Hoekstra OS, Honeywell RJ, Schuit RC, Meijerink M, Schwarte LA, Peters GJ, Verheul HMW, Lammertsma AA, Menke-van der Houven van Oordt CW. Mammatas LH, et al. J Nucl Med. 2021 Jul 1;62(7):934-940. doi: 10.2967/jnumed.120.251611. Epub 2020 Oct 30. J Nucl Med. 2021. PMID: 33127619 Free article.
Sorafenib administered using a high-dose, pulsatile regimen in patients with advanced solid malignancies: a phase I exposure escalation study.
Mammatas LH, Zandvliet AS, Rovithi M, Honeywell RJ, Swart EL, Peters GJ, Menke-van der Houven van Oordt CW, Verheul HMW. Mammatas LH, et al. Cancer Chemother Pharmacol. 2020 May;85(5):931-940. doi: 10.1007/s00280-020-04065-5. Epub 2020 Apr 9. Cancer Chemother Pharmacol. 2020. PMID: 32274565 Free PMC article. Clinical Trial.
11 results